1 / 13

Combination Products: Preparing for the Journey March 28, 2006

Understand regulations, strategic planning, and relationships with regulatory bodies for successful product development. Learn how to apply for designation and establish a strong rapport with the Office of Combination Products (OCP).

johncmorgan
Download Presentation

Combination Products: Preparing for the Journey March 28, 2006

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pamela J. Weagraff Principal Consultant Combination Products: Preparing for the Journey March 28, 2006

  2. Combination Products –Preparing for the Journey • Consider and understand the law, know the regulations, make use of available resources - why is obvious to understand how your product will be regulated but what about . . . • When: in earliest phase of product development as part of establishing Regulatory strategy • Where and Who: Office of Combination Products - Mark Kramer, Director, and staff, of Center Jurisdictional Offices • What and How: Office of Combination Product’s web site, http://www.fda.gov/oc/combination

  3. Preparing for the Journey – When? • First Phase of Product Development - Regulatory Strategy: assignment to a center with primary jurisdiction, or a lead center, is based on a determination of the “primary mode of action” (PMOA) of the combination product; develop . . . • A brief description of the product and its major components, intended use of the product, (clinical/therapeutic claims, including patient population) • An explanation of the product’s modes of action (how the product works); which mode of action is primary and attributable to device, drug or biologic • Consider need for formal or informal request for designation

  4. Preparing for the Journey – When? • Informal or Formal Request for Designation (RFD): consider . . . • Known FDA experience with similar products, established precedents – suggests informal RFD • Mitigation of business risk or lack of similar products – suggests formal RFD

  5. Preparing for the Journey – Where and Who? • Establish a relationship with the Office of Combination Products Staff: • Assignment of combination products – to Product Assignment Officer or Director • Regulatory identity of a product as a drug, device, biological product, tissue (HCT/P) or combination product – to Product Classification Officer or Director • Premarketing or post-marketing issues, including requests for facilitation or guidance – to either the Associate Director or the Senior Scientific Advisor • General policy or regulatory issues – to Director or Associate Director

  6. Preparing for the Journey – Where and Who? • Establish a relationship: if you are reasonably certain of designation, questions can be directed to Center jurisdictional offices • CBER: Sheryl Lard-Whiteford, Ph.D., 301-827-0379 • CDRH: Eugene Berk, 240-276-0104 • CDER: Warren Rumble, 301-443-5581

  7. Preparing for the Journey – What and How? • Apply the OC Resources – Informal RFD • Contact either OCP or Center Jurisdictional Office • Present information developed as part of Regulatory Strategy: • Brief description of the product / major components, intended use, (clinical/therapeutic claims, including patient population) • Explanation of modes of action (MOA) (how the product works); which MOA is primary and attributable to device, drug or biologic • Request feedback on center assignment

  8. Preparing for the Journey – What and How? • Apply the OC Resources – Formal RFD • Determine proceeding directly to RFD or submitting Pre-RFD • Contact OCP Director • Discuss plan for Pre-RFD and RFD or proceeding directly to RFD, provide Regulatory Strategy information • Request feedback on plan • Develop Pre-RFD or RFD according to OCP Guidance: “How to Write a Request for Designation”, August 2005, contact Leigh Hayes, OCP, 301-427-1934

  9. Preparing for the Journey – What and How? • Pre-RFD or RFD: • Follow the guidance document; contact Leigh Hayes, OCP, 301-427-1934, with any questions • Logistics: • Electronic submissions accepted • OCP review for completeness = 5 days • If complete per regulation / guidance, distributed to qualified individuals in Centers for review • OCP RFD review = 60 days

  10. We’re off and assigned . . . Now what?

  11. Ask Questions, All of Them! • What good manufacturing practice regulations apply to combination products? • How are adverse events reported for combination products? • How will user fees for our combination product be applied? • What kind of safety and effectiveness information will be needed to support approval of our combination product? • How can master files can be used in the submission of information relevant to our combination product?

  12. Work the Relationship with OCP • Include OCP staff in meetings with designated Center personnel for Pre-IND or Pre-IDE meetings, cc on submission cover letter • Keep OCP staff apprised of project status and request assistance in event of disputes, informal or formal • Become VERY familiar with the OCP web site

  13. “Chance favors the prepared mind.”--  Louis Pasteur Thank you! Pamela J. Weagraff, MBA, RAC Principal Consultant, Medical Device Development Quintiles Consulting Tel: 508-528-1745 E-Mail: pamela.weagraff@quintiles.com

More Related